Lan, Xiaoli
Younis, Muhsin H.
Li, Ke
Cai, Weibo
Article History
First Online: 23 August 2021
Declarations
:
: Weibo Cai is a scientific advisor, stockholder, and grantee of Focus-X Therapeutics, Inc. All other authors declare no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
Free to read: This content has been made available to all.